Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Age-related Vision Dysfunction Market is set to witness immense growth during the forecast period 2022-2028. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/players/vendors analysis, segments & sub-segments, and forecast. The report also focuses on market drivers, challenges (current and future), revenue growth, future roadmap, standardization, deployment models, and forecast analysis.
Overview:
A person with age-related macular degeneration (AMD) may need physical or financial assistance. Even simple tasks, such as walking or doing laundry, can become difficult. The person may require assistance with daily living activities or go to medical appointments. Their physical and financial well-being will be affected. They will also need assistance with daily chores, such as grocery shopping, or transportation to and from doctor's visits. Wet macular degeneration is another type of age-related macular degeneration. This form is more serious than dry AMD and is associated with a higher risk of permanent vision loss. Patients with wet AMD should visit their doctor for ongoing screenings and treatment. It's important to follow the doctor's recommendations as to when to see a specialist. The doctor can prescribe a prescription for a medication to slow the progression of the disease.
The global age-related vision dysfunction market focuses on six regions, such as North America, Asia Pacific, South America, Europe, the Middle East, and Africa.
Drivers:
The increasing prevalence of the geriatric population in the world is expected to fuel the growth of the global age-related vision dysfunction market over the forecast period. For instance, according to the United Nations, in 2019, there were around 703 million individuals in the world who are 65 years or more. There are several risk factors for age-related vision dysfunction, including smoking, high blood pressure, and cholesterol. Females are at increased risk as well, as are those with light eyes. During a routine eye exam, a doctor will check the retina (the layer of tissue in the back of the eye) for signs of age-related macular degeneration. While wet age-related vision dysfunction is not inherited, it can still lead to vision loss. If left untreated, it can cause permanent loss of central vision. Those with age-related vision dysfunction should see an eye care professional if symptoms persist. Early treatment is crucial to prevent the condition from progressing any further. Using a checkerboard-like grid, doctors determine whether straight lines appear missing, wavy, or blurry. During the test, the patient must focus on a central dot with an uncovered eye. If the lines appear blurry or wavy, the patient should contact their doctor. The increasing introduction of advanced treatment options is estimated to enhance the growth of the global age-related vision dysfunction market.
Restraints:
Less awareness related to age-related macular degeneration is expected to hinder the growth of the global age-related vision dysfunction market.
Regional Insights:
In regions, the Asia Pacific is expected to hold a major share of the global age-related vision dysfunction market, owing to the high prevalence of the geriatric population in the region. For instance, according to the European Union reports, around 28.7 % of the Japanese population are 65 years or more. Moreover, North America is estimated to witness significant growth in the global age-related vision dysfunction market owing to the increasing incidence of age-related eye health issues in the region. The high expansion of ophthalmologic centers in the region is assessed to drive the market growth.
Competitive Section:
Key players operating in the global age-related vision dysfunction market include Valeant Pharmaceuticals International, Inc., Santen Pharmaceuticals Co., Rxi Pharmaceuticals Inc., Regeneron Pharmaceuticals, Pfizer Inc, Ophthotech Corporation, Novartis AG, GlaxoSmithKline PLC, F. Hoffmann La Roche, Bayer AG, Bausch & Lomb Incorporated, ALLERGAN, Alimera Sciences Inc., and Acucela Inc.
Age-related Vision Dysfunction Market Dynamics:
This market study estimates the market size in terms of both value (million USD) and volume (K Units). The Age-related Vision Dysfunction Market report analyses market trends based on historical data and the latest developments. It provides both qualitative and quantitative data on the elements that will shape the market's growth from 2022 to 2028. The market capacity and consumption potential of major companies are discussed in this research report. Furthermore, it concentrates on prominent regions (Latin America, Europe, Asia Pacific, Africa, and the Middle East). Also, the report evaluates COVID-19's impact on the Age-related Vision Dysfunction Market.
Companies profiled in the Age-related Vision Dysfunction Market report include:
- Hoffman La Roche
- Eyenovia
- Allergan/AbbVie and Molecular Therapeutics
- Regenxbio
- Novartis
- Santen
- Nicox Ophthalmics
- Kodiak Sciences
- Opthea Limited
- Ocular Therapeutix
- Orasis Pharmaceuticals
- IVERIC bio
- Alkeus Pharmaceuticals
- Outlook Therapeutics
- Sun Pharma Advanced Research Company Limited
The report covers extensive competitive intelligence which includes the following data points:
⇨ Business Overview
⇨ Business Model
⇨ Financial Data
⇨ Financial – Existing
⇨ Financial – Funding
⇨ Product/Service Segment Analysis and specification
⇨ Recent Development and Company Strategy Analysis
⇨ SWOT Analysis
Segmentation by Type:
The type segment contributed the largest share to the Age-related Vision Dysfunction Market in 2021; this segment is projected to grow at the highest CAGR from 2022 to 2028.
- Faricimab
- Brolucizumab
- AGN-190584
- KSI-301
- RGX-314
Segmentation by Application:
An end-use industry is projected to grow at the highest CAGR during the forecast period, due to rapid development in emerging economies North America, APAC, MEA, Europe, and ROW.
- Healthcare
- Clinic
- Pharmacies
- Other
Key Benefits for Stakeholders:
- The study represents a quantitative analysis of the present Age-related Vision Dysfunction Market trends, estimations, and dynamics of the market size from 2022 to 2028 to determine the most promising opportunities.
- Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
- In-depth analysis, as well as market size and segmentation, help you identify current Age-related Vision Dysfunction Market opportunities.
- The largest countries in each region are mapped according to their revenue contribution to the market.
- The Age-related Vision Dysfunction Market research report gives a thorough analysis of the current status of the Age-related Vision Dysfunction Market's major players.
Reasons to Purchase Age-related Vision Dysfunction Market Report:
- Both current and future prospects for the Age-related Vision Dysfunction Market in developed and emerging markets.
- Analysis of various perspectives of the market with the help of Porter’s five forces analysis.
- During the forecast period, major regions are expected to see the most rapid increase.
- Identify the most recent advancements, Age-related Vision Dysfunction Market shares, and top market players' strategies.
Research Methodology:
To estimate and validate the size of the Age-related Vision Dysfunction Market and many other dependent submarkets in the overall market, both top-down and bottom-up methodologies are utilized. Key players in the market have been identified through secondary research and their market shares have been determined through primary and secondary research. Secondary sources and verified primary sources were used to determine all percentage share splits and breakdowns.
